Partial Response to Pyrotinib Plus Capecitabine in an Advanced Breast Cancer Patient with HER2 Amplification and R157W Mutation After Anti-HER2 Treatment: A Case Report and Literature Review

Human epidermal growth factor receptor2 (HER2) overexpression/amplification is associated with high malignancy, rapid disease progression and poor overall survival in breast cancer. The application of anti-HER2 drugs has greatly improved the survival of patients with HER2-positive breast cancer, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Yanchun, Liu, Yufeng, Ding, Kailin, Li, Yong, Hong, Xiaoyu, Zhang, Haibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936716/
https://www.ncbi.nlm.nih.gov/pubmed/33688205
http://dx.doi.org/10.2147/OTT.S289876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936716/
https://www.ncbi.nlm.nih.gov/pubmed/33688205
http://dx.doi.org/10.2147/OTT.S289876

Ejemplares similares